United Kingdom

Arix Bioscience plc

Track

Track

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.8
Andrew Smith Non-Executive Director Executive Director
Transaction date
Purchase
Price
463.25
Quantity 53,874
Value £877,490
Peregrine Moncreiffe Non-Executive Director and Chair of the Board Executive Director
Transaction date
Purchase
Price
129.26
Quantity 24,652
Value £3,939,909
Peregrine Moncreiffe Non-Executive Director and Chair of the Board Executive Director
Transaction date
Purchase
Price
95.96
Quantity 49,748
Value £4,715,962
2.0
Robert Lyne Chief Executive Officer Officer
Transaction date
Purchase
Price
1.07
Quantity 107,657
Value £115,094
2.0
Robert Lyne Chief Executive Officer Officer
Transaction date
Sale
Price
1.05
Quantity 107,657
Value £112,669
Peregrine Moncreiffe Non-Executive Director and Chair of the Board Executive Director
Transaction date
Purchase
Price
1.04
Quantity 160,000
Value £165,962
2.0
Robert Lyne Chief Executive Officer Officer
Transaction date
Purchase
Price
1.03
Quantity 24,330
Value £24,999
Peregrine Moncreiffe Non-Executive Director and Chair of the Board Executive Director
Transaction date
Purchase
Price
1.09
Quantity 200,000
Value £217,000
Peregrine Moncreiffe Non-Executive Director and Chair of the Board Executive Director
Transaction date
Purchase
Price
1.04
Quantity 75,000
Value £78,000
Peregrine Moncreiffe Non-Executive Director and Chair of the Board Executive Director
Transaction date
Purchase
Price
102.94
Quantity 1,000
Value £102,942
Sir Michael Bunbury Non-Executive Director and Senior Independent Director (SID) Non-Executive Director
Transaction date
Purchase
Price
1.00
Quantity 47,600
Value £47,600
Peregrine Moncreiffe Non-Executive Director and Chair of the Board Executive Director
Transaction date
Purchase
Price
1.19
Quantity 84,000
Value £99,960
2.0
Robert Lyne CEO and General Counsel Officer
Transaction date
Purchase
Price
1.20
Quantity 41,666
Value £49,999
Naseem Amin Executive Chairman Director
Transaction date
Purchase
Price
2.06
Quantity 183,000
Value £376,980
Marcus Karia Group Finance Director Executive Director
Transaction date
Purchase
Price
0.86
Quantity 11,604
Value £9,999
2.0
Robert Lyne Chief Operating Officer Officer
Transaction date
Purchase
Price
0.86
Quantity 23,255
Value £19,999
2.9
Jonathan Peacock Chairman Director
Transaction date
Purchase
Price
2.25
Quantity 90,000
Value £202,500
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-11-10 2023-11-09 B Purchase
2.8
Andrew Smith

Non-Executive Director

Executive Director
53,874
463.25
£877,490 		53,874 463.25 £877,490
2023-11-03 2023-11-03 B Purchase
Peregrine Moncreiffe

Non-Executive Director and Chair of the Board

Executive Director
24,652
129.26
£3,939,909 		24,652 129.26 £3,939,909
2023-11-02 2023-11-02 B Purchase
Peregrine Moncreiffe

Non-Executive Director and Chair of the Board

Executive Director
49,748
95.96
£4,715,962 		49,748 95.96 £4,715,962
2023-05-04 2023-05-04 B Purchase
2.0
Robert Lyne

Chief Executive Officer

Officer
107,657
1.07
£115,094 		107,657 1.07 £115,094
2023-05-04 2023-05-04 S Sale
2.0
Robert Lyne

Chief Executive Officer

Officer
107,657
1.05
£112,669 		107,657 1.05 £112,669
2023-05-02 2023-04-28 B Purchase
Peregrine Moncreiffe

Non-Executive Director and Chair of the Board

Executive Director
160,000
1.04
£165,962 		160,000 1.04 £165,962
2023-05-02 2023-04-27 B Purchase
2.0
Robert Lyne

Chief Executive Officer

Officer
24,330
1.03
£24,999 		24,330 1.03 £24,999
2023-02-06 2023-02-06 B Purchase
Peregrine Moncreiffe

Non-Executive Director and Chair of the Board

Executive Director
200,000
1.09
£217,000 		200,000 1.09 £217,000
2022-10-28 2022-10-27 B Purchase
Peregrine Moncreiffe

Non-Executive Director and Chair of the Board

Executive Director
75,000
1.04
£78,000 		75,000 1.04 £78,000
2022-10-05 2022-10-04 B Purchase
Peregrine Moncreiffe

Non-Executive Director and Chair of the Board

Executive Director
1,000
102.94
£102,942 		1,000 102.94 £102,942
2021-12-17 2021-12-16 B Purchase
Sir Michael Bunbury

Non-Executive Director and Senior Independent Director (SID)

Non-Executive Director
47,600
1.00
£47,600 		47,600 1.00 £47,600
2021-12-17 2021-12-16 B Purchase
Peregrine Moncreiffe

Non-Executive Director and Chair of the Board

Executive Director
84,000
1.19
£99,960 		84,000 1.19 £99,960
2021-12-17 2021-12-16 B Purchase
2.0
Robert Lyne

CEO and General Counsel

Officer
41,666
1.20
£49,999 		41,666 1.20 £49,999
2020-12-21 2020-12-18 B Purchase
Naseem Amin

Executive Chairman

Director
183,000
2.06
£376,980 		183,000 2.06 £376,980
2020-04-17 2020-04-16 B Purchase
Marcus Karia

Group Finance Director

Executive Director
11,604
0.86
£9,999 		11,604 0.86 £9,999
2020-04-17 2020-04-16 B Purchase
2.0
Robert Lyne

Chief Operating Officer

Officer
23,255
0.86
£19,999 		23,255 0.86 £19,999
2018-03-21 2018-03-20 B Purchase
2.9
Jonathan Peacock

Chairman

Director
90,000
2.25
£202,500 		90,000 2.25 £202,500
Explore more

More insider trading research around Arix Bioscience plc

More insider trades in United Kingdom
Insider trading in Europe